Agios Pharmaceuticals' Mitapivat Approval Boosts Revenue
Update: 2025-12-24
Description
Agios Pharmaceuticals mitapivat, sold as Aqvesme, gains FDA approval for treating anemia in thalassemia patients, potentially unlocking $320M in peak revenue.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
